Abstract:Background Traditionally, the purpose of a dose-finding design in cancer is to find the maximum tolerated dose based solely on toxicity. However, for molecularly targeted agents, little toxicity may arise within the therapeutic dose range and the dose-response curves may not be monotonic. This challenges the principle that more is better, which is widely accepted for conventional chemotherapy. Methods We propose three adaptive dose-finding designs for trials evaluating molecularly targeted agents, for which the dose-response curves are unimodal or plateaued. The goal of these designs is to find the optimal biological dose, which is defined as the lowest dose with the highest rate of efficacy while safe. The first proposed design is parametric and assumes a logistic dose-efficacy curve for dose finding, the second design is nonparametric and uses the isotonic regression to identify the optimal biological dose, and the third design has the spirit of a semiparametric' approach by assuming a logistic model only locally around the current dose. Results We conducted extensive simulation studies to investigate the operating characteristics of the proposed designs. Simulation studies show that the nonparametric and semiparametric designs have good operating characteristics for finding the optimal biological dose. Limitations The proposed designs assume a binary endpoint. Extension of the proposed designs to ordinal and time-to-event endpoints is worth further investigation. Conclusion Among the three proposed designs, the nonparametric and semiparametric designs yield consistently good operating characteristics and thus are recommended for practical use. The software to implement these two designs is available for free download at http://odin.mdacc.tmc.edu/similar to yyuan/.

D-optimal Approximate Design for Binary Regression and Quantal Response in Toxicology Studies

Adaptive designs for identifying optimal biological dose for molecularly targeted agents.

A Bayesian Quasi-Likelihood Design for Identifying the Minimum Effective Dose and Maximum Utility Dose in Dose-Ranging Studies

Identification of Optimal Strategies for State Transition of Complex Biological Networks.

Optimal designs for dose-finding experiments in toxicity studies

On the Relative Efficiency of Model-Assisted Designs: a Conditional Approach.

Using particle swarm optimization to search for locally $D$-optimal designs for mixed factor experiments with binary response

Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes

Hybrid algorithms for generating optimal designs for discriminating multiple nonlinear models under various error distributional assumptions

Optimal designs for dose–response models with linear effects of covariates

Gboin: a Unified Model-Assisted Phase I Trial Design Accounting for Toxicity Grades, and Binary or Continuous End Points

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

MT-Keyboard: A Bayesian Model-assisted Interval Design to Account for Toxicity Grades and Types for Phase I Trials

LOCALLY D-OPTIMAL DESIGNS FOR HIERARCHICAL RESPONSE EXPERIMENTS

An Adaptive Trial Design to Optimize Dose-Schedule Regimes with Delayed Outcomes

D ‐optimal designs for multi‐response linear models with two groups

Time-to-event Model-Assisted Designs for Dose-Finding Trials with Delayed Toxicity

$D$-Optimal and Nearly $D$-Optimal Exact Designs for Binary Response on the Ball

D-optimal Designs for Multinomial Logistic Models

Orthogonal Array Based Locally D-Optimal Designs for Binary Responses in the Presence of Factorial Effects

Robustness of Optimal Designs for 2^2 Experiments with Binary Response